Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mobix Labs (MOBX) Other Accumulated Expenses (2023 - 2025)

Mobix Labs has reported Other Accumulated Expenses over the past 3 years, most recently at $3.3 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 69.31% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, up 69.31%, while the annual FY2025 figure was $3.2 million, 44.44% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $3.3 million at Mobix Labs, up from $3.2 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $3.3 million in Q4 2025 and troughed at $963000.0 in Q3 2023.
  • A 3-year average of $2.0 million and a median of $1.9 million in 2024 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 130.63% in 2024 and later rose 14.3% in 2025.
  • Year by year, Other Accumulated Expenses stood at $1.5 million in 2023, then skyrocketed by 33.33% to $2.0 million in 2024, then skyrocketed by 69.31% to $3.3 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for MOBX at $3.3 million in Q4 2025, $3.2 million in Q3 2025, and $1.9 million in Q2 2025.